1. Home
  2. STG vs KPTI Comparison

STG vs KPTI Comparison

Compare STG & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunlands Technology Group

STG

Sunlands Technology Group

HOLD

Current Price

$2.84

Market Cap

50.1M

Sector

Real Estate

ML Signal

HOLD

Logo Karyopharm Therapeutics Inc.

KPTI

Karyopharm Therapeutics Inc.

HOLD

Current Price

$1.79

Market Cap

47.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STG
KPTI
Founded
2003
2008
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.1M
47.6M
IPO Year
2017
2013

Fundamental Metrics

Financial Performance
Metric
STG
KPTI
Price
$2.84
$1.79
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$16.00
AVG Volume (30 Days)
21.0K
1.2M
Earning Date
05-21-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$146,067,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$22.36
P/E Ratio
$1.10
N/A
Revenue Growth
N/A
0.57
52 Week Low
$2.44
$1.72
52 Week High
$8.74
$10.99

Technical Indicators

Market Signals
Indicator
STG
KPTI
Relative Strength Index (RSI) 36.41 26.02
Support Level $2.55 N/A
Resistance Level $3.64 $2.18
Average True Range (ATR) 0.18 0.16
MACD 0.00 0.23
Stochastic Oscillator 29.00 5.95

Price Performance

Historical Comparison
STG
KPTI

About STG Sunlands Technology Group

Sunlands Technology Group operates in China's adult online education market and adult personal interest learning market through its online platforms. The Group has a deep understanding of the educational needs of its prospective students and offers solutions to help them achieve their goals. It provides online professional courses and educational content, including interest, professional skills, professional certification preparation courses, and degree- or diploma-oriented post-secondary courses. The Group adopts a counseling-oriented sales and marketing approach to offer education solutions based on students' backgrounds and goals, delivering adult online education and personal interest learning through extensive course and content offerings.

About KPTI Karyopharm Therapeutics Inc.

Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).

Share on Social Networks: